Early Briefing and Review: Boston Scientific Corp., Abbott Laboratories, Zimmer Holdings Inc., and EnteroMedics Inc.

LONDON, September 20, 2013 /PRNewswire/ --

On Thursday, September 19, 2013, the S&P 500 ended the day at 1,722.34, down 0.18%; the Dow Jones Industrial Average closed at 15,636.55, down 0.26%; while the NASDAQ Composite finished at 3,789.38, up 0.15%. Shares in medical appliances and equipment industry edged lower, even as the broader market fluctuated between gains and losses. The major movers in the sector included Boston Scientific Corporation (NYSE: BSX), Abbott Laboratories (NYSE: ABT), Zimmer Holdings Inc. (NYSE: ZMH), and EnteroMedics Inc. (NASDAQ: ETRM). AAAResearchReports.com has released free charting and technical research on these aforementioned companies. Register to read these reports at:

http://www.aaaresearchreports.com/register/  

On Thursday, Boston Scientific Corp.'s stock fell sharply to close at $11.74, down 1.59% from the previous day's closing price of $11.93. The company's shares vacillated between $11.72 and $11.98 during the trading session. A total of 13.38 million shares were traded, which is below the daily average volume of 16.92 million. Despite Thursday's sharp decline, the company's shares have advanced 6.82% in the last one month and 24.89% in the previous three months, outperforming the S&P 500 which has gained 4.63% and 5.73% during the respective periods. Additionally, Boston Scientific Corp.'s stock is trading above its 50-day and 200-day moving averages of $10.88 and $8.42, respectively. Sign up for free report on BSX at:

http://www.AAAResearchReports.com/BSX092013.pdf

Shares in Abbott Laboratories fell by 0.87% on Thursday, reversing some of the gains from the previous trading session. The company's shares closed the day at $35.34 after oscillating between $35.29 and $35.72. A total of 6.41 million shares were traded, which is below the daily average volume of 7.04 million. Despite Thursday's losses, the company's shares have advanced 0.94% in the previous three trading sessions and 1.32% in the last one month, compared to a gain of 1.46% and 4.63% in the S&P 500 during the respective periods. Furthermore, Abbott Laboratories stock is trading above its 50-day and 200-day moving averages of $35.25 and $34.88, respectively. ABT free technical report can be accessed by signing up at:

http://www.AAAResearchReports.com/ABT092013.pdf

On Thursday, Zimmer Holdings Inc.'s shares edged lower to end the day at $83.51, which is 0.30% lower than the previous day's closing price of $83.76. The company's shares fluctuated between $83.33 and $83.84 during the trading session. A total of 0.67 million shares were traded, which is below the daily average volume of 0.93 million. Despite Thursday's pullback, Zimmer Holdings Inc.'s shares have gained 4.87% in the last one month and 7.15% in the previous three months, outperforming the S&P 500 which has gained 4.63% and 5.73% during the respective periods. Moreover, the company's stock is trading above its 50-day and 200-day moving averages of $81.39 and $76.09, respectively. A free report on ZMH can be accessed by registering at:

http://www.AAAResearchReports.com/ZMH092013.pdf

EnteroMedics Inc.'s stock declined on Thursday, reversing some of the gains from the previous trading session. The company's shares ended the session 0.78% lower at $1.27 after trading between $1.23 and $1.32. A total of 0.91 million shares were traded, which is above the daily average volume of 0.71 million. Despite Thursday's decline, the company's stock is up 4.10% in the previous three trading sessions and 25.74% in the last one month, compared to a gain of 1.46% and 4.63% in the S&P 500 during the respective periods. Further, EnteroMedics Inc.'s stock is trading above its 50-day moving average of $1.09. Register with AAA Research Reports and download research on ETRM for free at:

http://www.AAAResearchReports.com/ETRM092013.pdf

----

EDITOR NOTES:

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AAAresearchreports.com

SOURCE AAA Research Reports